NCT07787871 Effect of Acupressure on Postoperative Pain After Laparoscopic Totally Extraperitoneal Inguinal Hernia Repair
| NCT ID | NCT07787871 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medipol University |
| Condition | Postoperative Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2026-06-20 |
| Primary Completion | 2026-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 90 participants in total. It began in 2026-06-20 with a primary completion date of 2026-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized, sham-controlled clinical trial aims to evaluate the effect of acupressure on postoperative pain following laparoscopic totally extraperitoneal (TEP) inguinal hernia repair. A total of 90 participants will be randomly assigned to one of three groups: standard postoperative care alone (control group), true acupressure plus standard care, or sham acupressure plus standard care. Acupressure will be applied at postoperative hours 1, 4, and 8 using the bilateral P6 (Neiguan), LI4 (Hegu), ST36 (Zusanli), and SP6 (Sanyinjiao) acupoints. The sham group will receive pressure at non-acupuncture points. The primary outcome is postoperative pain intensity measured using the Visual Analog Scale (VAS). Secondary outcomes include analgesic consumption, postoperative nausea and vomiting, time to mobilization, patient satisfaction, and postoperative complications.
Eligibility Criteria
Inclusion Criteria: * Adults aged 18 to 75 years * Diagnosis of a unilateral primary inguinal hernia * Scheduled to undergo elective laparoscopic total extraperitoneal (TEP) inguinal hernia repair * American Society of Anesthesiologists (ASA) physical status I to III without an anticipated need for postoperative intensive care * Ability to understand the study procedures and provide written informed consent Exclusion Criteria: Bilateral inguinal hernia * Recurrent inguinal hernia * Strangulated inguinal hernia * History of open lower abdominal surgery * Skin infection, wound, or surgical scar at any of the acupressure application sites * ASA physical status III with an anticipated need for postoperative intensive care * ASA physical status IV * Participation in another clinical study within the previous 4 weeks * Receipt of acupressure or a similar complementary treatment within the previous 4 weeks * Refusal or inability to provide written informed consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07787871 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Postoperative Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07787871 currently recruiting?
Yes, NCT07787871 is actively recruiting participants. Contact the research team at ahmet.yaz@std.medipol.edu.tr for enrollment information.
Where is the NCT07787871 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07787871 clinical trial?
NCT07787871 is sponsored by Medipol University. The trial plans to enroll 90 participants.